FR1536251A - Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque - Google Patents

Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque

Info

Publication number
FR1536251A
FR1536251A FR107483A FR107483A FR1536251A FR 1536251 A FR1536251 A FR 1536251A FR 107483 A FR107483 A FR 107483A FR 107483 A FR107483 A FR 107483A FR 1536251 A FR1536251 A FR 1536251A
Authority
FR
France
Prior art keywords
dihydroxy
preparation
butenoic acid
acid lactones
lactones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR107483A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Priority to FR107483A priority Critical patent/FR1536251A/fr
Application granted granted Critical
Publication of FR1536251A publication Critical patent/FR1536251A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR107483A 1966-05-24 1967-05-23 Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque Expired FR1536251A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR107483A FR1536251A (fr) 1966-05-24 1967-05-23 Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55239766A 1966-05-24 1966-05-24
US62940067A 1967-04-10 1967-04-10
FR107483A FR1536251A (fr) 1966-05-24 1967-05-23 Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque

Publications (1)

Publication Number Publication Date
FR1536251A true FR1536251A (fr) 1968-08-16

Family

ID=27244131

Family Applications (1)

Application Number Title Priority Date Filing Date
FR107483A Expired FR1536251A (fr) 1966-05-24 1967-05-23 Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque

Country Status (1)

Country Link
FR (1) FR1536251A (fr)

Similar Documents

Publication Publication Date Title
OA03403A (fr) Procédé de préparation de nouveaux dérivés de l'acide benzoyl-3 phénylacétique.
CH436246A (fr) Procédé de préparation de dérivés de l'acide transchrysanthémique
CH472399A (fr) Procédé de préparation de l'ester méthylique de l'acide 9 , 15 -dihydroxyprost-13-énoïque
FR1391480A (fr) Procédé de préparation de dérivés de l'acide hydroxy-phényl-acétique
CH475231A (fr) Procédé de préparation d'esters furfuryliques de l'acide chrysanthémumique
FR1452737A (fr) Procédé de préparation d'acide monoperphtalique stable
FR1536251A (fr) Procédé de préparation des lactones de l'acide 4, 4-dihydroxy-2-buténoïque
FR1522839A (fr) Procédé de préparation de polyesters de l'acide acétyl-acétique
CH471767A (fr) Procédé de préparation de dérivés de l'acide hydroxybenzoïque
FR1448087A (fr) Procédé de préparation d'acide trans-4-aminométhylcyclohexane-1-carboxylique
FR1464263A (fr) Procédé de préparation d'esters de l'acide 16, 17, 18-tri-épi-déserpidique
FR1534765A (fr) Procédé de préparation de lactones de l'acide 4-hydroxy-2-buténoïque
CH513101A (fr) Procédé de préparation de l'acide benzophénonetricarboxylique 3,4,4'
FR1462259A (fr) Procédé de préparation de l'acide delta3-pyrroline-2-carboxylique
CH434236A (fr) Procédé de préparation de l'acide 11-iodo-10-undécynoïque
FR1515766A (fr) Procédé de préparation de l'acide hydroxytéréphtalique
CH468346A (fr) Procédé de préparation de l'acide 1-amino-3-carboxy-2-propanesulfonique
FR1457593A (fr) Procédé de préparation de dérivés de l'acide oméga-hydroxydodécanoïque
FR1439643A (fr) Procédé de préparation d'acide 3, 6-endoxotétrahydrophtalique
FR1462796A (fr) Procédé de préparation de l'acide 4'-nitrodiphényl-4-carboxylique
FR1433279A (fr) Procédé de préparation de l'acide 5'-guanylique
CH473755A (fr) Procédé de préparation d'esters de l'acide 4-oxo-5-alcoylpentanoïque
CH491093A (fr) Procédé de préparation des nouveaux dérivés de l'acide sulfamyl-benzoïque
FR1545420A (fr) Procédé de préparation du dianhydride de l'acide 2. 3. 5. 6-pyrazine-tétracarboxylique
FR1541884A (fr) Procédé perfectionné de préparation de l'éthylauramine